May 17, 2022
Calendar
11:00am - 12:00pm
Eastern
The pandemic may have accelerated sponsors embracing decentralized clinical trials faster than originally intended, demonstrating real benefits to patients, sites, and sponsors. For all the benefits DCT technology bring, it presents additional complexities related to patient data privacy and regulatory compliance adherence that are critical for continued success and global expansion.
In this session, our panel of experts share what sponsors should be aware of when designing clinical trials, and how decentralized clinical trial technology addresses needs surrounding patient data privacy standards and regulatory compliance across all geographies.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
